Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
The DOI matches its Crossref record; 373 of the 373 references it cites were found in a registry or an index.
Abstract
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and amyotrophic lateral sclerosis. The treatment of the same remains a daunting challenge due to the limited access of therapeutic moieties across the blood–brain barrier. Engineered nanoparticles with a size less than 100 nm provide multifunctional abilities for solving these biomedical and pharmacological issues due to their unique physico‐chemical properties along with capability to cross the blood–brain barrier. Needless to mention, there is a scarcity of review articles summarizing recent developments of various nanomaterials including liposomes, polymeric nanoparticles, metal nanoparticles, and bio‐nanoparticles toward the therapeutic and theranostics applications for various neurodegenerative disorders. Here, a broad spectrum of nanomedicinal approaches to eradicate neurodegenerative disorders is provided, along with a brief account of neuroprotection and neuronal tissue regeneration, current clinical status, issues related to safety, toxicity, challenges, and future outlook.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using nanocarriers like liposomes, nanoparticles, and micelles, radiopharmaceuticals can be protected, ensuring their delicate contents remain intact, while also offering improved compatibility and extended circulation within the body [63].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [63]
In the citing paper
“Owing to their unique physicochemical properties and inherent ability to penetrate the BBB, engineered NPs with dimensions below 100 nm show considerable promise in addressing a range of biological and pharmacological challenges [65].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [65]
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationPericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Research works printed but not linked: 13
- Birks J. S., 2018, Cochrane Database Syst. Rev., 6, CD001190
- Carlesi C., 2011, Arch. Ital. Biol., 149, 151
- Chen W., 2018, Adv. Mater., 30
- Fu T., 2016, Neural Plast., 2016, 1
- Wang Y. L., 2018, Zhonghua Yixue Zazhi, 98, 2678
- Cummings J., 2017, J. Prev. Alzheimers Dis., 4, 109
- Hickey P., 2011, Drug Des., Dev. Ther., 5, 241
- Fernandez H. H., 2016, npj Parkinson's Dis., 2, 1
- 10.1002/adma.201801362 · DOI · Paper page
- Shin J. W., 2016, Hum. Mol. Genet., 25, 4566
- Sone D., 2019, Mol. Psychiatry
- Yusuf M., 2012, Int. J. Nanomed., 7, 4311
- Carpenter D. O., 2001, Int. J. Occup. Med. Environ. Health, 14, 209
Cited by
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Self-citationOuyang, J., Xie, A., Zhou, J., Liu, R., Wang, L., Liu, H., Kong, N., & Tao, W. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01148k · Cited by 385
Kumarasamy, R. V., Natarajan, P. M., Umapathy, V. R., Roy, J. R., Mironescu, M., & Palanisamy, C. P. (2024) · Frontiers in Nanotechnology · doi:10.3389/fnano.2024.1479993 · Cited by 191
Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors
Zhang, L., Liu, Y., Huang, H., Xie, H., Zhang, B., Xia, W., & Guo, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114536 · Cited by 176
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“Using nano-carriers like liposomes, nanoparticles, and micelles, radiopharmaceuticals can be protected, ensuring their delicate contents remain intact, while also offering improved compatibility and extended circulation within the body [63].”
BackgroundmRNA nanomedicine: Design and recent applications
Kubiatowicz, L. J., Mohapatra, A., Krishnan, N., Fang, R. H., & Zhang, L. (2022) · Exploration · doi:10.1002/exp.20210217 · Cited by 138
Gold nanostructures: synthesis, properties, and neurological applications
Zare, I., Yaraki, M. T., Speranza, G., Najafabadi, A. H., Shourangiz-Haghighi, A., Nik, A. B., Manshian, B. B., Saraiva, C., Soenen, S. J., Kogan, M. J., et al. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01111a · Cited by 133
Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer’s and Parkinson’s Diseases
Jagaran, K., & Singh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169082 · Cited by 126
2D materials-based nanomedicine: From discovery to applications
Ouyang, J., Rao, S., Liu, R., Wang, L., Chen, W., Tao, W., & Kong, N. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114268 · Cited by 112
Oxidative stress modulating nanomaterials and their biochemical roles in nanomedicine
Patel, K. D., Keskin‐Erdogan, Z., Sawadkar, P., Sharifulden, N. S. A. N., Shannon, M. R., Patel, M., Silva, L. V. B., Patel, R., Chau, D. Y. S., Knowles, J. C., et al. (2024) · Nanoscale Horizons · doi:10.1039/d4nh00171k · Cited by 110
Huang, D., Wang, Q., Cao, Y., Yang, H., Li, M., Wu, F., Zhang, Y., Chen, G., & Wang, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12840 · Cited by 107
Xie, X., Tang, J., Xing, Y., Wang, Z., Ding, T., Zhang, J., & Cai, K. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002138 · Cited by 101
Choi, G., Rejinold, N. S., Piao, H., & Choy, J. (2021) · Chemical Science · doi:10.1039/d0sc06724e · Cited by 97
Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles
Morse, S. V., Mishra, A., Chan, T. G., de Rosales, R. T. M., & Choi, J. J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.005 · Cited by 95
Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders
Du, L., Roy, S., Wang, P., Li, Z., Qiu, X., Zhang, Y., Yuan, J., & Guo, B. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102230 · Cited by 95
Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 88
Advances in nanomedicines for diagnosis of central nervous system disorders
Zhang, X., Zhou, J., Gu, Z., Zhang, H., Gong, Q., & Luo, K. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120492 · Cited by 85
Fakhri, S., Abdian, S., Zarneshan, S. N., Moradi, S. Z., Farzaei, M. H., & Abdollahi, M. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s347187 · Cited by 85
Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease
Taliyan, R., Kakoty, V., Sarathlal, K. C., Kharavtekar, S. S., Karennanavar, C. R., Choudhary, Y. K., Singhvi, G., Riadi, Y., Dubey, S. K., & Kesharwani, P. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.044 · Cited by 80
Zhu, Y., He, M., Lin, C., Ma, W., Ai, Y., Wang, J., & Liang, Q. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502178 · Cited by 77
Nayab, D. E., Din, F. U., Ali, H., Kausar, W. A., Urooj, S., Zafar, M., Khan, I., Shabbir, K., & Khan, G. M. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02250-1 · Cited by 78
Liu, W., Dong, X., Liu, Y., & Sun, Y. P. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.018 · Cited by 75
La Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Inorganic Nanomaterials versus Polymer-Based Nanoparticles for Overcoming Neurodegeneration
Martano, S., Matteis, V. D., Cascione, M., & Rinaldi, R. (2022) · Nanomaterials · doi:10.3390/nano12142337 · Cited by 69
Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier
Beygi, M. H. M., Oroojalian, F., Azizi‐Arani, S., Hosseini, S. S., Mokhtarzadeh, A., Kesharwani, P., & Sahebkar, A. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202310881 · Cited by 68
Moorthy, H., & Govindaraju, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01319 · Cited by 64
He, X., Xie, J., Zhang, J., Wang, X., Jia, X., Yin, H., Qiu, Z., Yang, Z., Chen, J., Ji, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104286 · Cited by 62
Liu, Z., Ma, M., Yu, D., Ren, J., & Qu, X. (2020) · Chemical Science · doi:10.1039/d0sc04984k · Cited by 62
Advances in nanotechnology versus stem cell therapy for the theranostics of Huntington's disease
Channa, G. M., Hassan, D., Zeeshan, M., Ruiz-Pulido, G., Ebrahimi, N., Mobashar, A., Pourmadadi, M., Rahdar, A., Sargazi, S., Fathi‐karkan, S., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104774 · Cited by 61
Kochman, U., Sitka, H., Kuźniar, J., Czaja, M., Kozubek, P., Beszłej, J. A., & Leszek, J. (2026) · Molecular Neurobiology · doi:10.1007/s12035-025-05417-z · Cited by 60
Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders
Guo, Z.-H., Khattak, S., Rauf, M. A., Ansari, M. A., Alomary, M. N., Razak, S., Yang, C., Wu, D., & Ji, X. (2023) · Molecules · doi:10.3390/molecules28031283 · Cited by 59
Lee, J. H., Rim, Y. S., Min, W. K., Park, K.-H., Kim, H. T., Hwang, G., Song, J., & Kim, H. J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202107074 · Cited by 55
Mohapatra, P., Gopikrishnan, M., Doss, C. G. P., & Chandrasekaran, N. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s442520 · Cited by 54
Polymeric nanocarriers for therapeutic gene delivery
Zhang, J., Yang, X., Chang, Z., Zhu, W., Ma, Y., & He, H. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101015 · Cited by 51
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
Puranik, N., Yadav, D., & Song, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814044 · Cited by 50
Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging
Thangam, R., Paulmurugan, R., & Kang, H. (2021) · Nanomaterials · doi:10.3390/nano12010018 · Cited by 47
Photoactive Nanomaterials for Wireless Neural Biomimetics, Stimulation, and Regeneration
Zhao, D. S., Huang, R., Gan, J.-M., & Shen, Q. (2022) · ACS Nano · doi:10.1021/acsnano.2c08543 · Cited by 47
Light‐Driven Micromotors to Dissociate Protein Aggregates That Cause Neurodegenerative Diseases
Burrezo, P. M., Mayorga‐Martinez, C. C., & Pumera, M. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106699 · Cited by 47
Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management
Karthika, V., Sridharan, B., Nam, J. W., Kim, D., & Lim, H. G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02406-7 · Cited by 48
Conklin, B., Conley, B. M., Hou, Y., Chen, M., & Lee, K.-B. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114636 · Cited by 45
Thangam, R., Patel, K. D., Kang, H., & Paulmurugan, R. (2021) · Vaccines · doi:10.3390/vaccines9080935 · Cited by 45
Hossein, H. H. S., Jabbari, I., Zarepour, A., Zarrabi, A., Ashrafizadeh, M., Taherian, A., & Makvandi, P. (2020) · Molecules · doi:10.3390/molecules25184053 · Cited by 43
Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers
Boyuklieva, R., Zahariev, N., Simeonov, P., Penkov, D., & Katsarov, P. (2025) · Biomedicines · doi:10.3390/biomedicines13061464 · Cited by 38
Khute, S., & Jangde, R. (2023) · Current Therapeutic Research · doi:10.1016/j.curtheres.2023.100714 · Cited by 38
Alahri, M. B., Ibrahim, A. J., Barani, M., Arkaban, H., Shadman, S. M., Salarpour, S., Zarrintaj, P., Jaberi, J., & Jalil, A. T. (2023) · Molecules · doi:10.3390/molecules28020841 · Cited by 37
Nanomedicine-based immunotherapy for Alzheimer's disease
Hoque, M., Samanta, A., Alam, S. S. M., Zughaibi, T. A., Kamal, M. A., & Tabrez, S. S. M. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104973 · Cited by 34
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Multifunctional Nanocarriers for Alzheimer’s Disease: Befriending the Barriers
Ansari, M. A., Tripathi, T., Venkidasamy, B., Monziani, A., Rajakumar, G., Alomary, M. N., Alyahya, S. A., Onimus, O., D’souza, N., Barkat, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03730-z · Cited by 33
Zhang, S., Li, M., Li, Y., Yang, S., Wang, J., Ren, X., Wang, X., Bai, L., Huang, J., Geng, Z., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03258-5 · Cited by 32
Targeted delivery of berberine using bionic nanomaterials for Atherosclerosis therapy
Wu, H., Zhang, L., Dong, X., Yang, J., Liang, Z., Li, L., Liu, X., Jin, M., & Zhang, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117135 · Cited by 31
El-Nablaway, M., Rashed, F., Taher, E. S., Foda, T., Abdeen, A., Abdo, M., Fericean, L. M., Bănățean-Dunea, I., Mihaela, O., Dinu, Ş., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122671 · Cited by 30
Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier
Zhang, J., Yang, T., Huang, W., Yu, Y., & Sun, T. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220527121943 · Cited by 30
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Kanwal, H., Sangineto, M., Ciarnelli, M., Castaldo, P., Villani, R., Romano, A. D., Serviddio, G., & Cassano, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074050 · Cited by 29
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Zhang, L., Sun, H., Zhao, J., Lee, J., Low, L. E., Gong, L., Chen, Y., Wang, N., Zhu, C., Lin, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113832 · Cited by 28
Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases
Bolideei, M., Barzigar, R., Gahrouei, R. B., Mohebbi, E., Haider, K. H., Paul, S., Paul, M. K., & Mehran, M. J. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10857-0 · Cited by 28
Self-citationExtracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Zhu, C., Yang, Y., Li, X., Chen, X., Lin, X., & Wu, X. (2022) · Nano Research · doi:10.1007/s12274-021-4066-8 · Cited by 26
Singh, S., Hema, Sharma, N., Sachdeva, M., Behl, T., Zahoor, I., Fuloria, N. K., Sekar, M., Fuloria, S., Subramaniyan, V., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-22830-2 · Cited by 24
Calatayud, D. G., Jardiel, T., Cordero-Oyonarte, E., Caballero, A. C., Villegas, M., Valle-Noguera, A., Cruz‐Adalia, A., & Peiteado, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063410 · Cited by 24
Mendake, R. A., Hatwar, P. R., Bakal, R. L., Hiwe, K. A., & Barewar, S. S. (2024) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2024.27.3.0222 · Cited by 23
Wang, Y., Liao, X., Guo, Q., Zhang, H., Ye, L., Yu, L., Kong, X., Jiang, Y., Zhao, P., Cai, K., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.033 · Cited by 22
Neurodegenerative diseases and brain delivery of therapeutics: Bridging the gap using dendrimers
Kaur, A., Singh, N., Kaur, H., Kakoty, V., Sharma, D. S., Khursheed, R., Babu, M. R., Harish, V., Gupta, G., Gulati, M., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104868 · Cited by 21
Zhang, D., Kong, J., Huang, X., Zeng, J., Du, Q., Yang, T., Yue, H., Bao, Q., Miao, Y., Xu, Y., et al. (2023) · Materials Today Nano · doi:10.1016/j.mtnano.2023.100347 · Cited by 21
Phuna, Z. X., Panda, B. P., Shivashekaregowda, N. K. H., & Madhavan, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102921 · Cited by 19
Responsive Supramolecular Polymers for Diagnosis and Treatment
Martínez‐Orts, M., & Pujals, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074077 · Cited by 19
Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives
Zakharova, L. Y., Gaynanova, G. A., Vasilieva, E. A., Vasileva, L. A., Pavlov, R. V., Kashapov, R. R., Petrov, K. A., & Sinyashin, O. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867330666221115103513 · Cited by 18
Panda, P., Kar, S. S., & Mohapatra, R. (2024) · Next Materials · doi:10.1016/j.nxmate.2024.100336 · Cited by 18
“Plurol will not miss the boat”: A new manifesto of galantamine conveyance
Gad, H. A., Mansour, M., Abbas, H., Malatani, R. T., Khattab, M. A., & Elmowafy, E. M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103516 · Cited by 18
Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases
Bhosale, A., Paul, G., Mazahir, F., & Yadav, A. K. (2022) · OpenNano · doi:10.1016/j.onano.2022.100111 · Cited by 17
Nano-mediated Management of Metal Toxicity-induced Neurodegeneration: A Critical Review
Dubey, P. R., Kaur, G., & Shukla, R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04782-z · Cited by 17
Palaniselvam, S., Narasimman, V., Vijayashree, R., & Ramachandran, S. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115523 · Cited by 16
Peng, F., Jeong, S., Ho, A., & Evans, C. L. (2021) · Cytometry Part A · doi:10.1002/cyto.a.24489 · Cited by 16
Lin, X., Dong, X., & Sun, Y. P. (2024) · Small · doi:10.1002/smll.202407154 · Cited by 16
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Nguyen, T. T., Nguyen‐Thi, P., Nguyen, T. H. A., Ho, T.-T., An, T. N. M., Toi, V. V., & Giau, V. V. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00654-1 · Cited by 15
Nanomedicine targets endogenous copper ions for disease diagnosis and therapy
Li, X., Cui, Y., Zhou, T., Li, J., Pei, L., Yuwen, L., Wang, L., & Weng, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144951 · Cited by 15
Toxicological Aspects of Iron Oxide Nanoparticles
Fernández‐Bertólez, N., Costa, C., Brandão, F., Teixeira, J. P., Pásaro, E., Valdiglesias, V., & Laffón, B. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-88071-2_13 · Cited by 14
Chakraborty, P., Bhattacharyya, C., Sahu, R., Dua, T. K., Kandimalla, R. J. L., & Dewanjee, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105267 · Cited by 13
Wang, Y., Liu, W., Sun, Y. P., & Dong, X. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00073 · Cited by 12
Zhang, L., Mao, Z., Li, W., Chi, S., Cheng, H., Wang, Z., Wang, C., & Liu, Z. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c02767 · Cited by 12
Carbon-based nanotechnology for Parkinson’s disease: diagnostic and therapeutic innovations
Lafi, Z., Asha, S., & Asha, S. Y. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2535940 · Cited by 12
Paramagnetic Functionalization of Biocompatible Scaffolds for Biomedical Applications: A Perspective
Bettini, S., Bonfrate, V., Valli, L., & Giancane, G. (2020) · Bioengineering · doi:10.3390/bioengineering7040153 · Cited by 12
Advances in Gold Nanoparticles for the Diagnosis and Management of Alzheimer’s Disease
Sivamaruthi, B. S., Kesika, P., Sisubalan, N., & Chaiyasut, C. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091158 · Cited by 11
Emerging Selenium Nanoparticles for CNS Intervention
Malik, J. A., AjgarAnsari, J., Ahmed, S., Rani, A., Ansari, S. Y., & Anwar, S. (2023) · Biomedical engineering · doi:10.5772/intechopen.109418 · Cited by 11
Neuroanatomical Tract Tracers: Not Just for Neural Tracing Anymore
Wang, W., Clark, J., & Mao, G. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00063 · Cited by 11
Calatayud, D. G., Jardiel, T., Bernardo, M. S., Mirabello, V., Ge, H., Arrowsmith, R. L., Cortezon‐Tamarit, F., Alcaraz, L., Isasi, J., Arévalo-Cid, P., et al. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01417 · Cited by 11
Senousy, M. A., Eid, A. H., Zaki, M. B., Abd‐Elmawla, M. A., Ghaiad, H. R., El‐Shiekh, R. A., Ahmed, S., & Khalifa, H. O. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1794983 · Cited by 10
Le, H. T. N., Giang, V. T. T., Abioye, A. O., & Adejare, A. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020192 · Cited by 10
Youssef, B., Ibrahim, E. A., Moselhy, S. S., ElShebiney, S. A., & ELabd, W. K. (2025) · Discover Nano · doi:10.1186/s11671-025-04356-x · Cited by 9
Jeevanandam, J., Tsenov, G., Danquah, M. K., Ruiz‐Molina, D., Boussios, S., & Ovsepian, S. V. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00813-6 · Cited by 9
Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases
Zhang, L., Sun, H., Chen, Y., Wei, M., Lee, J., Li, F., & Ling, D. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1696 · Cited by 9
Aptamer-nanoconjugates as emerging theranostic systems in neurodegenerative disorders
Aggarwal, N., Choudhury, S., Chibh, S., & Panda, J. J. (2021) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2021.100554 · Cited by 9
Chiral nanomaterials for neurodegenerative diseases
Wang, Y., Jia, X., & Jiang, X. (2024) · Biomedical Analysis · doi:10.1016/j.bioana.2024.04.001 · Cited by 8
Mishra, A., Payne, C., Carrascal-Miniño, A., Sunassee, K., Halbherr, S., Pouliopoulos, A. N., & de Rosales, R. T. M. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114183 · Cited by 8
Alijanpourtolouti, O., Senanayake, G., Kõks, S., & Henry, D. J. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00066a · Cited by 8
Olasehinde, T. A., Olisah, C., & Olaniran, A. O. (2024) · Studies in natural products chemistry · doi:10.1016/b978-0-443-15628-1.00004-0 · Cited by 8
Ikram, M. D., & Rasheed, S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220819143105 · Cited by 8
Beura, S. K., Maharaj, S., Kumari, N., Yadav, R., Sahu, M., Khilar, L. R., Yadav, N., Sahoo, G., Panigrahi, A. R., Yadav, P., et al. (2024) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-72467-1_14 · Cited by 7
Gold nanoparticles: diagnostic and therapeutic applications in neurodegenerative disorders
Hu, X., Cheng, J., Yuan, R., Zhou, Y., Rao, J., Wan, Y., Li, Y., Zhang, X., & Li, R. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2509287 · Cited by 8
Santhosh, A. J. S., Karthik, R., & Suganthi, K. (2025) · Computer Science Review · doi:10.1016/j.cosrev.2025.100821 · Cited by 6
Nanomedicine breakthroughs in cancer and neurodegenerative disease therapy
Haque, A., Khan, T., Islam, R. U., & Naseem, S. (2025) · Next Nanotechnology · doi:10.1016/j.nxnano.2025.100233 · Cited by 6
Metadata
- Authors
- Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A.
- Affiliations
- Rice University (US)
- Mayo Clinic (US)
- Birla Institute of Technology and Science, Pilani (IN)
- Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center 986025 Nebraska Medical Center Omaha NE 68198‐6025 USA
- University of California, Los Angeles (US)
- Aavishkar Oral Strips Pvt. Ltd. 109/3, IDA, Phase 2, Sector 2, Lane 6, Cherlapally Hyderabad Telangana 500051 India
- Corresponding author
- Mukherjee, Sudip
- Paul, Manash Kumar
- Mukherjee, Anubhab
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-06-16
- Volume
- 30
- Issue
- 35
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W3036302963
- Cited by
- 152
- References
- 371
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 29 · 2023: 24 · 2022: 29 · 2021: 22 · 2020: 4
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Functional Materials (publishedVersion)
- Funders
- Rice University
- University of California, Los Angeles
- Mayo Clinic
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- nanomedicine, neurodegenerative diseases, theranostics, blood-brain barrier, engineered nanoparticles, liposomes, polymeric nanoparticles, metal nanoparticles, bionanoparticles, Alzheimer's disease, Parkinson's disease, Huntington's disease, prion disease, amyotrophic lateral sclerosis, neuroprotection, nanoparticle toxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.